A pharmacy transfer involves much more than just moving premises. Between submitting the file to the ARS and the actual opening at the new point of sale, several months pass, marked by regulatory deadlines that do not always overlap as expected. Understanding these timeframes is what separates a well-managed project from a schedule that derails.
ARS Processing Time and Deferred Effect of Transfer Authorization
A technical point structures the entire schedule: the processing time starts from the receipt of a complete file, not from the mere submission of the request. The ARS then has four months to make a decision. An incomplete file resets the clock to zero, which can delay the entire project by several weeks.
In case of refusal, the pharmacist can initiate an administrative or contentious appeal within two months following the notification. This appeal rarely suspends the decision and significantly extends the timeline.
The authorization obtained does not allow for immediate opening. The decree takes effect three months after its notification, and the opening to the public must occur within a maximum period of two years. This delay requires synchronizing the lease of the new premises, the financing of the work, and the closure of the old site with a timeframe that does not depend on the pharmacist.
A holder who initiates the steps for a pharmacy transfer without factoring in these non-negotiable deadlines risks paying rent on an empty premises for several months or finding themselves without a lease when the authorization becomes effective.
Pharmacy Transfer and Sale: Comparative Table of Procedures
The confusion between transfer and sale is common, but these two operations follow distinct processes, with different timelines and contacts.
| Criterion | Pharmacy Transfer | Pharmacy Sale |
|---|---|---|
| Subject | Geographical relocation of the activity | Change of ownership (with or without relocation) |
| Main Authority | ARS (prefectural decree) | ARS + Order of Pharmacists |
| Processing Time | Four months from the complete file | Four to six months (including price escrow) |
| Effect of Authorization | Three months after notification | Immediate after registration of the deed |
| Legal Advertising | Not required | Mandatory (legal announcement, registration) |
| Price Escrow | Not applicable | Price sometimes held for several months |
A project that combines transfer and sale (purchase of a pharmacy with relocation) accumulates both processes. The temporary escrow of the sale price can immobilize cash flow for a duration that is difficult to predict, complicating the financing plan for the renovation work.
Why This Distinction Changes the Timeline
In a pure transfer, the holder retains their license and relocates their activity. The only hurdle is the ARS. In a sale, registration with the Order, legal advertising, and escrow add non-negotiable steps. A pharmacist who plans their project as a simple transfer when it involves a sale risks underestimating the total duration by several months.
ARS File for Pharmacy Transfer: Blocking Documents
The file submitted to the ARS must demonstrate that the transfer improves the pharmaceutical service in the area concerned. The required documents vary depending on whether the relocation remains within the same municipality, changes neighborhoods, or crosses a municipal boundary.
- The area study is the most scrutinized document: it must document the served population, traffic flows, the presence of healthcare professionals nearby, and the demographic evolution of the area. A rushed or generic study motivates the majority of requests for additional information.
- The plan of the future premises, with detailed surfaces (dispensing area, back-office, confidentiality zone), must prove compliance with current operating standards. An incomplete or unmeasured plan leads to a rejection of completeness.
- The property certificate or the draft lease for the new premises must be attached. Without a formalized real estate commitment, the ARS considers the file premature.
- If applicable, the opinion of the competent Order council is required, especially when the transfer alters the distribution of pharmacies in the area.
A file declared incomplete resets the four-month deadline to zero. Each back-and-forth with the ARS costs time and weakens the negotiation of the lease or bank financing.
Synchronizing Lease, Work, and Closure of the Old Site
The most costly trap of a pharmacy transfer lies in the simultaneous management of two premises. The lease of the old site often still runs when the new premises require renovation work.
Negotiating an early exit clause on the old lease before submitting the ARS file reduces this risk. Waiting for authorization to begin this negotiation exposes the holder to several months of double rent.
Work and Compliance of the New Premises
The renovation of the new point of sale must comply with accessibility, confidentiality, and storage standards for pharmaceutical products. Work can only start after the lease is signed, which itself is conditioned by the progress of the ARS file.
A realistic timeline places the lease signing just after obtaining authorization, the work during the three-month effect period of the decree, and the opening to the public as soon as the decree becomes effective. Any delay in one of these milestones pushes back the following ones.
Communication with the pharmacy team and patients deserves to be planned in parallel. A well-prepared transfer relies as much on the administrative timeline as on the logistical ground. The pharmacist who anticipates each regulatory window maintains control of their project, whereas improvisation generates difficult-to-absorb additional costs.
